David Natan's Insider Trades & SAST Disclosures

David Natan's most recent trade in Sunshine Biopharma Inc was a trade of 100,000 Common Stock done . Disclosure was reported to the exchange on April 14, 2026.

Share

Note

This is a custom search result for pattern David Natan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Sunshine Biopharma Inc	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Apr 2026	100,000	100,000	-		0	Common Stock
Sow Good Inc	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.47 per share.	30 Mar 2026	276,876	276,876	-	0.5	128,775	Common Stock
Indaptus Therapeutics Inc	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2026	25,000	25,000	-		-	Option to Buy Common Stock
Cyclacel Pharma Inc	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	700,000	700,000	-		-	Non-Qualified Stock Option (Right to Buy)
Cyclacel Pharma Inc	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	100,000	100,000 (0%)	0%		-	Common Stock
Opgen Inc	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Apr 2024	100,000	100,000 (1%)	1%		-	Common Stock
Titan Pharma Inc (de)	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2023	100,000	100,000	-		-	Option to Purchase Common Stock
Titan Pharma Inc (de)	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2023	50,000	50,000 (0%)	0%		0	Common Stock
Titan Pharma Inc (de)	David Natan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2023	25,000	25,000	-		-	Option to Purchase Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades